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Background. Changes in serotype prevalence among pneumococcal populations result from both serotype
replacement and serotype (capsular) switching. Temporal changes in serotype distributions are well documented,
but the contribution of capsular switching to such changes is unknown. Furthermore, it is unclear to what extent
vaccine-induced selective pressures drive capsular switching.
Methods. Serotype and multilocus sequence typing data for 426 pneumococci dated from 1937 through 2007
were analyzed. Whole-genome sequence data for a subset of isolates were used to investigate capsular switching
events.
Results. We identiﬁed 36 independent capsular switch events, 18 of which were explored in detail with whole-
genome sequence data. Recombination fragment lengths were estimated for 11 events and ranged from approxi-
mately 19.0 kb to ≥58.2 kb. Two events took place no later than 1960, and the imported DNA included the
capsular locus and the nearby penicillin-binding protein genes pbp2x and pbp1a.
Conclusions. Capsular switching has been a regular occurrence among pneumococcal populations throughout
the past 7 decades. Recombination of large DNA fragments (>30 kb), sometimes including the capsular locus and
penicillin-binding protein genes, predated both vaccine introduction and widespread antibiotic use. This type of
recombination has likely been an intrinsic feature throughout the history of pneumococcal evolution.
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Streptococcus pneumoniae (the “pneumococcus”) is an
asymptomatic colonizer of the human nasopharynx
and a major cause of otitis media, sinusitis, pneumo-
nia, and meningitis, resulting in approximately 14.5
million annual serious disease episodes globally
among young children [1]. The primary virulence de-
terminant is its polysaccharide capsule, of which there
are 94 known serotypes [2–6]. The capsule protects
against phagocytosis during invasive pneumococcal
disease and may also prevent clearance during naso-
pharyngeal colonization [7, 8]. Ninety-two capsule
types are synthesized and exported through the “Wzy-
dependent” pathway, whereby extracellular polymeri-
zation of component lipid-linked repeat units is
preceded by “ﬂippase-mediated” transfer across the
cell membrane [2, 9]. The proteins involved are
encoded by the capsule polysaccharide synthesis (cps)
genes, located between dexB and aliA on the chromo-
some. The remaining 2 capsule types are synthesized
through independent biochemical pathways.
Sequence analyses of 88 reference cps loci revealed
variable lengths (approximately 10–30 kb) and a
range of genes speciﬁc to capsule production [2]. The
serotype-nonspeciﬁc genes were present among all
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Wzy-dependent capsule types, whereas serotype-speciﬁc genes
were only found among 1 or a subset of types. Unique
serotypes, and further diversity within serogroups, evolved
through a combination of mutation and interspecies/intraspecies
recombination [2, 10–13].
Serotype is a key determinant of invasive pneumococcal
disease potential and prevalence; certain serotypes are more
commonly associated with carriage and others more common-
ly with invasive pneumococcal disease [14, 15]. A 7-valent
pneumococcal conjugate vaccine (PCV7) was introduced in
the United States in 2000 [16] and, subsequently, into many
other countries. Ten-valent and 13-valent vaccines (PHiD-CV
and PCV13, respectively) contain polysaccharides targeted
against the original 7 serotypes (4, 6B, 9V, 14, 18C, 19F, and
23F) plus serotypes 1, 5, and 7F (both vaccines) and 3, 6A,
and 19A (PCV13 only) and have now replaced PCV7 [17, 18].
Surveillance following PCV7 introduction showed a decline
of vaccine type (VT) and an increase of nonvaccine type
(NVT) pneumococci in disease and nasopharyngeal carriage
[19]. This can be attributed to the phenomena of “serotype
replacement,” the expansion of preexisting NVT pneumococci,
and/or “serotype switching,” a change of serotype of a single
clone by alteration or exchange of its cps locus [20]. (Serotype
switching was ﬁrst described by Grifﬁth in 1928 [21] and was
the focus of the transformation studies by Avery and col-
leagues in 1944 [22].) These effects are not completely inde-
pendent: capsular switch variants can subsequently expand
within a population. Both phenomena can be studied by com-
parison of the serotypes and genotypes present in populations
before and after introduction of pneumococcal vaccines. Pneu-
mococcal genotypes, as deﬁned by multilocus sequence typing
(MLST) [23], show serotype-speciﬁc associations [14, 24]; any
isolate exemplifying a different genotype/serotype combina-
tion may represent a capsular switch variant. Such variants
usually arise by recombination at the cps locus, and studies of
a limited number of such strains indicated that recombination
fragment sizes varied from approximately 21.9 kb to app-
roximately 56.5 kb [25–28]. In some cases, the fragments also
included part or all of the pbp2x and pbp1a genes (2 of the 3 pri-
mary penicillin-resistance determining genes, located approxi-
mately 8 kb upstream and approximately 7 kb downstream of
the cps locus).
Vaccine-induced selective pressure is contributing to the
postvaccination changes of serotype epidemiology, but
natural ﬂuctuations in serotype prevalence also play a role.
Many studies have documented prevaccine temporal changes
in relative serotype prevalence: all but 3 included pneumo-
cocci isolated no earlier than 1969; only 2 studies provided
genotype data (Supplementary Materials). In this study,
we used serotyping, MLST, and whole-genome data to study
a large, genetically diverse collection of historical and
modern pneumococci, with the aim to better understand the
mechanisms and role of capsular switching in pneumococcal
evolution.
METHODS
Strains and Genome Sequencing
A global collection of 426 pneumococci recovered during
1937–2007 (Supplementary Materials) were previously sero-
typed by the Quellung reaction and genotyped by MLST [23]
to determine the sequence type (ST). Closely related isolates
were assigned to clonal complexes (CCs) by a modiﬁed goe-
BURST method [29] (Supplementary Materials). CCs were
named after the predicted founder ST. When no single
founder ST could be determined, CCs were named NoneX,
where X was the ST of lowest numeric value within the CC.
Isolates of the same CC but with different serotypes were pre-
sumed to be capsular switch variants.
A total of 96 genetically diverse isolates from our collection
were selected for whole-genome sequencing (Supplementary
Materials and Table 1) on the Illumina platform as previously
described [30]. Seven were excluded as technical failures. Raw
sequence data were assembled using Velvet [31], and contigs
were deposited in a BIGS database (BIGSdb) [32]. Sequence
data were deposited in the European Nucleotide Archive (Sup-
plementary Table 1).
Nucleotide Sequence Analysis
Eight CCs were represented by isolates subjected to whole-
genome sequencing and were selected for further cps locus
analysis; 7 CCs included capsular switch variants. Within each
CC, the ancestral serotype was assumed to be the most
common one or that of the oldest isolate. cps sequence align-
ments for study isolates and published loci were used to inves-
tigate serotype changes. Nucleotide sequences of the cps locus,
and upstream/downstream ﬂanking sequences where appro-
priate, were aligned using MUSCLE [33] and imported to
MEGA5 [34] for visual inspection of variable sites. When re-
combination at the cps locus was predicted, potential donor
representatives were sought from our whole-genome se-
quenced isolates, the cps locus reference sequences, and an ad-
ditional 131 pneumococcal genomes retrieved from GenBank.
Putative donors were identiﬁed as isolates for which the cps
locus differed from that of the recombinant by a maximum of
3 nucleotides (excluding clusters of closely linked substitu-
tions, which were considered to have arisen through recombi-
nation within the cps locus itself ). MLST data were used to
infer the CC most likely represented by the true donor isolate
(the same as that of the donor representative). Recombination
regions were identiﬁed as the minimum region over which the
recombinant representative (hereafter, the “recombinant”) dif-
fered from the ancestral representative (hereafter, the “ances-
tor”) and was identical or highly similar (>99.7% sequence
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identity) to the donor representative (hereafter, the “donor”).
Where no suitably matched donor was identiﬁed, the maximum
recombination region was estimated as the maximum length
over which the recombinant differed from the ancestor (Supple-
mentary Materials).
RESULTS
Indication of Serotype Switching
Among the entire collection of 426 pneumococci, 21 of 163
unique CCs were represented by isolates of 2–6 serotypes. At
least 36 independent changes of serotype within CCs were rep-
resented in our collection, 34 of which predated the introduc-
tion of pneumococcal conjugate vaccines (Figure 1).
Within-CC cps Diversity
CC15
Seven of 10 CC1514 (CC15, serotype 14) cps locus sequences
were unique (Table 1). Isolates ICE13 and ICE50 shared wciY
locus nucleotide substitutions with 4 CC12414 representatives
(isolates 14/9, USA6, Ala289, and ICE594), suggesting a possi-
ble recombination event between these CCs. The CC1514 rep-
resentatives had a 432-bp deletion in the wciY gene, resulting
in a predicted 250-amino-acid truncation of the protein.
Isolate CGSP14 [35] also had an additional 52-bp deletion
within the wciY gene; if this represented a true deletion event
rather than a sequencing/assembly error, the resultant protein
would be further reduced to 38 amino acids.
CC66
Ten CC66 isolates, dated 1952–2005, represented 5 serotypes.
The oldest isolate was serotype 7B; the next oldest was a sero-
type 9N from 1960. An approximately 53.4-kb region of se-
quence of the serotype 9N isolate, including pbp2x, the cps
locus, and pbp1a, differed from the CC667B isolate but was
highly similar to a CC37829N isolate dated 1952 (Table 2 and
Figure 2). (Although the data strongly suggest that a
CC37829N pneumococcus was the donor in this case, it is pos-
sible that another clone not represented in this sample was the
true donor. Thus, we use the term “CCXX-like” when describ-
ing putative donors.) Within the cps locus, a second CC669N
isolate differed from the oldest CC669N isolate by only 5 nu-
cleotide substitutions (Table 1).
Sequences of the 2 CC6619F genomes suggested 2 indepen-
dent capsular switches, but no potential 19F donors were
identiﬁed. The putative imports were estimated as the regions
over which these genomes clearly differed from those of
CC669N; independent recombination breakpoints were indi-
cated (Table 2 and Figure 2).
There were 3 independent capsular switches among 4
CC6614 representatives. On the basis of sequence similarity,
the donors for 2 events were CC1514-like, while the third was
CC12414-like. The breakpoints for 1 event could not be deter-
mined because of extensive diversity in the cps ﬂanking
regions, but breakpoints for the others were estimated
(Table 2 and Figure 2). Interestingly, the 5′ breakpoints for 2
serotype 14 switches and one of the aforementioned
serotype 19F switches were all 2.2–2.5 kb upstream of
dexB (in the ATCC700669 reference genome [36], this
corresponds to the clpL locus, which has been shown to be
involved in modulating the expression of virulence-related
genes [37] and in the development of penicillin nonsuscepti-
bility [38]).
The single CC6623F representative in our collection differed
from the CC669N isolates from approximately 2 kb upstream
of dexB to approximately 3 kb downstream of aliA, suggesting
a potential recombination import of approximately 30.4 kb,
but no suitable donor was identiﬁed.
Figure 1. Temporal distribution of capsular switch variants among the historical isolate collection. Gray triangles indicate isolation dates for the
oldest recombinant representatives of 36 independent capsular switch events identiﬁed among the historical pneumococcal collection. Abbreviation:
PCV7, 7-valent pneumococcal conjugate vaccine.
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Table 1. Genetic Evolution at the cps Locus Among Isolates Representing the Same Pneumococcal Serotypes and Clonal Complexes
(CCs)
CCSerotype Isolate Year
Nucleotide Substitution(s) as
Compared to Ancestor (gene)
Recombination
Regions
1514 14/5 1967 NA …
PMEN10 1987 A8695G (wchM); missing bp 11 509–11 525 and bp 12 423–enda …
SPnINV200 1995 C12439T (wciY) …
ICE13 1998 C12466A and C12467A (wciY) …
Ala243 1998 C12439T (wciY) …
GA13338 1999 C12439T (wciY) …
Ala317 2001 None …
ICE50 2003 C12439T, C12466A, C12467A, and G12502A (wciY); 22-bp
insertion at position 11 509
…
CGSP14 2004–2005 C1010T (wzg) and C12439T (wciY); missing bp 11 488–11 539 cps bp 1–367
SP14-BS292 Unknown T1976A (wzh) and C12439T (wciY) …
669N 9N/6 1960 NA …
USA8 2001 A4399G (wchA), A14000G, T14014G, C14037T, and T14042C
(between ugd and IS1381 putative transposase)
…
11318C 18C/2 1939 NA …
18C/1b 1940 A2203G (wzd) …
18C/3 1968 G3478A (wze) …
Netherlands18C-36 1980 None …
USA2 1999 C4622T (wchA) cps bp 15 861–17 005
ICE501 2002 None …
12414 14/2b 1952 NA …
14/4 1961 A3109G and G3478A (wze), A5616G and C5617T (wchK), and
T6662A (wzy)
cps bp 12 330–12 467
PMEN35 1980 None; missing bp 12 437–enda …
14/9 1982 T11491C, A11524G, C12466A, C12467A, G12495A, and
A12505T (wciY)
…
14/7 1992 A4141G (wchA) …
Ala292 1998 C3816A and G4087A (wchA) …
USA6 1999 C43A (wzg), A12403G, C12466A, C12467A, and G12502A (wciY) …
Ala263 2002 None …
Ala289 2002 C12466A, C12467A, and G12502A (wciY) …
ICE46 2003 None …
ICE594 2005 C12466A, C12467A, and G12502A (wciY) …
CCR11974 G2455T (wzd) …
156/1629V 9V/5 1991 NA …
PMEN3 1993 None …
GA08780 1997 T5230C (wchO) …
SP9-BS68 Unknown None …
1917F 7F/3 1962 NA; missing bp 20 430–enda …
7F/5b 1962 A16G (wzg) …
Netherlands7F-39 1984 None; missing bp 20 434–enda …
7F/4 1986 None; missing bp 20 434–enda …
ICE22 1993 C20435T, A20436G, T20441C, and A20450G (glf ) …
CDC1087–00 1999 T10697C (wchF) …
USA16 2003 None …
21812F 12F/5 1988 NA …
Denmark12F-34 1995 G16593T (between fnlA and fnlB) …
12F/6 1996 G16593T (between fnlA and fnlB) and C18121T (fnlC) …
USA18 1999 G16593T (between fnlA and fnlB) …
CDC0288-04 2003–2004 C7397T (wzy), G16593T (between fnlA and fnlB), and C18121T
(fnlC)
…
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CC113
Eleven CC113 isolates represented serotypes 18C (n = 6), 35C
(n = 2), and 9V, 17F, and 18B (n = 1 each). Serotype 18C was
assumed to be the ancestral serotype and was also represented
by 1 of the 2 oldest isolates, both dated 1939. The change
from serotype 18C to 18B was due to a single nucleotide sub-
stitution within the wciX gene [2], while each of the other se-
rotype changes was associated with a recombination event.
Both CC11335C isolates likely arose from a single capsular
switch event (Table 2 and Figure 2). The serotype 17F change
appears to have involved DNA acquisition from a CC57417F-
like pneumococcus by a CC11335C pneumococcus. The 5′
region of the CC11317F cps locus was distinct from that of 3
other serotype 17F isolates in our collection but differed by
only 1 nucleotide substitution from the CC11335C representa-
tives. The CC11317F genome was highly similar to that of a
CC57417F isolate between position 549 of the wze locus and
approximately 3 kb downstream of pbp1a, after which the
CC11317F genome resembled that of the CC11318C isolates.
There was little to no variation at the cps locus among 5
CC11318C representatives (Table 1). A sixth isolate differed by
1 nucleotide in the wchA gene and by a putative import of
approximately 1.1 kb (marked by 44 nucleotide substitutions)
spanning the rmlA and rmlC genes (Figure 3A).
CC124
Twelve of 14 CC124 representatives were serotype 14 and rep-
resented 8 unique but highly similar cps sequences (Table 1).
Two isolates were serotypes 9L and 11C, but no suitable
donors were identiﬁed, and the cps ﬂanking regions of both
isolates were highly divergent from those of the CC12414 rep-
resentatives for ≥30 kb in either direction. Thus, the putative
recombination breakpoints could not be estimated.
CC156/162
Seven isolates (dated 1952–2006) representing serotypes 9V,
9A, and 19A were assigned to CC156/162. Four isolates were
serotype 9V; the oldest was serotype 9A. The CC156/1629A cps
locus differed from that of the oldest CC156/1629V locus by 2
nucleotides [2] (Table 2 and Figure 2). Three of the 4 CC156/
1629V cps loci were identical, and the other differed by 1
nucleotide.
Analysis of the cps loci and ﬂanking regions of the 2
CC156/16219A representatives (GenBank accession numbers
AGOR01000001–AGOR01000024 and AGQA01000001–
AGQA01000007) suggested a single capsular switch event.
Approximately 50.4-kb regions of the CC156/16219A genomes
were highly similar to those of a CC19919A isolate (Table 2
and Figure 2) and included pbp2x, the cps locus, and pbp1a.
The regions directly ﬂanking the putative import did not re-
semble those of the CC156/1629V representatives, and thus the
true recombination breakpoints could not be estimated.
However, we deduced that the original import was ≥50.4 kb.
CC191
Seven of the CC191 representatives were serotype 7F, and the
eighth, and oldest, was serotype 7A. Serotypes 7A and 7F dif-
fered by 3 nucleotides (Table 2 and Figure 4). There was a re-
peated motif (5′-CTA AGA TGA ATA-3′) within the wcwC
gene, and the number of repeats differed between isolates
(n = 3, 4, or 6). Repeat motifs are difﬁcult to sequence accurate-
ly, so further speculations about such changes cannot be made.
Apart from the repeat region, the CC1917F cps loci each differed
by a maximum of 4 nucleotides (Table 1 and Figure 3B).
CC218
Eight CC218 isolates represented serotypes 12F (n = 5) and 7F
(n = 3). Between approximately 9 kb upstream of pbp2x and
approximately 4.8 kb downstream of pbp1a, CC2187F and
CC1917F sequences were very similar, although differentiating
nucleotides were identiﬁed (Table 2). The clustering of 44 nu-
cleotide substitutions within the cps locus was indicative of re-
combination events (Figure 3B), but whether these events
occurred before or after the cps switch is unknown. Note that
approximately 585 bp were missing between pbp2x and dexB
in both CC2187F and CC1917F representatives. Table 1 pro-
vides additional details about nucleotide substitutions among
the cps loci of CC2187F and CC21812F isolates.
Table 1 continued.
CCSerotype Isolate Year
Nucleotide Substitution(s) as
Compared to Ancestor (gene)
Recombination
Regions
2187F 7F/2 1952 NA …
ICE23 1993 C5369A (wchF), C6499T (wcwA), and A12622C (wcwH) …
USA20 1999 C9059T (HG140), C11766G (wcwH); missing bp 20 431–enda …
Abbreviation: NA, not applicable.
a Likely due to sequencing/assembly failure.
b This isolate was used as the cps reference strain in reference [2].
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CC574
Two CC574 isolates were examined: a serotype 17F isolate from
1952 and a serotype 2 isolate from 1956. The sequences differed
from position 326 of dexB to approximately 5 kb downstream
of pbp1a. A region of the serotype 2 representative (totaling
approximately 35 kb, from approximately 0.6 kb downstream of
dexB to approximately 5 kb downstream of pbp1a) was highly
similar to that of a CCNone1282 representative dated 1916
(Table 2 and Figure 4). A short, 314-bp region of unknown se-
quence in the dexB locus was also present.
Table 2. Genetic Changes Leading to Capsular Switching Events Among Pneumococci
CC
Serotype
Change Yeara
PM
or R Point Mutation(s)
Recombination
cps Point Mutations as
Compared to DonorcDonor Breakpoints Import, kb
66 7B→9N 1960,
2001
R … CCNone37829N ≥8901 bp 5’ pbp2x–
7415 bp 3’ pbp1a
≥54.3 Noned
9N→19F 1972 R … Unk19F 2538 bp 5’ dexB–34 bp
5’ aliA
≤23.7 …
9N→19F 2005 R … Unk19F 115 bp 3’ dexB–bp 1173
aliA
≤20.6 …
9N→14 1995,
1999
R … CC1514 2158 bp 5’ dexB–
between bp 88 aliA
and 785 bp 3’ aliA
23.1–25.8 A8695G, G10976T, and
C12439T
9N→14 1997 R … CC1514 Und Und A4486G, A8695G, and
G10461Ae
9N→14 unka R … CC12414 ≥2520 bp 5’ dexB–4062
bp 3’ aliA
≥29.9 A1704G and T12439C
9N→23F 2001 R … Unk23F 1964 bp 5’ dexB–3013
bp 3’ aliA
≤30.4 …
113 18C→18B 1941b PM G12382T … … … …
18C→35C 1941,
1943b
R … Unk35C 144 bp 3’ dexB–76 bp 5’
aliA
≤19.0 …
35C→17F 1939 R … CC57417F bp 549 wze–3278 bp 3’
pbp1a
30.9 A8794G
18C→9V 1968b R … Unk9V Und Und …
124 14→11C 1957b R … Unk11C Und Und …
14→9L 1952 R … Unk9L Und Und …
156/162 9V→9A 1962b PM G1543A, deletion
bp 16 996
… … … …
9V→19A 2005,
2006
R … CC19919A ≥5701 bp 5’ dexB to
≥6022 bp 3’ aliA
≥ 50.4 None
191 7F→7A 1937b PM A2375G,
A10521T,
insertion bp
8606
… … … …
218 12F→7F 1952,
1993,
1999
R … CC1917F ≥9045 bp 5’ pbp2x–
4782 bp 3’ pbp1a
≥ 58.2 C6854A, C8089T,
and 2 putative
recombinations
marked by 39
nucleotide changes
bp 1083–1279 and 7
changes bp
19 486–20 473
574 17Fb→2 1956b R … CCNone1282 Between bp 326 dexB
and 639 bp 3’ dexB–
5229 bp 3’ pbp1a
34.9–36.8 G3294T, T3339C, and
G3956T
Abbreviations: CC, clonal complex; PM, point mutation; R, recombination; Unk, unknown; Und, undetermined.
a Year of recipient isolate(s) with the new serotype.
b This isolate was used as the cps locus reference strain in reference [2].
c Calculated over the region spanning the synthesis-related genes only (Supplementary Materials).
d Missing bp 14 006–15 542 (end) likely due to sequencing/assembly failure.
e Missing bp 12 437–12 516 (end) likely due to sequencing/assembly failure.
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Figure 2. Genetic changes leading to capsular switching within clonal complexes (CCs) 66, 113, and 156/162. Bars represent the cps locus and
ﬂanking regions. Filled arrows indicate the relative positions of the dexB (left) and aliA (right) loci. Open arrows indicate the relative positions of the
pbp2x (left) and pbp1a (right) loci. Vertical bisecting lines indicate single nucleotide substitutions. Recombination fragments are indicated by coloring.
Identical sequences are indicated by identical coloring. Regions bounded by solid lines are depicted at their maximum length. Regions not bounded by
solid lines are depicted at their minimum length (Table 2). The asterisk indicates a single-base-pair deletion. The schematic is drawn approximately to
scale.
Figure 3. Variable site maps for the cps loci of serogroups 18 and 7. Rows represent the nucleotide sequences of independent isolates and are
labeled as isolate name (year). Nucleotide differences relative to row 1 are shown. Periods indicate an identical base, and hyphens indicate a missing
base. Numbers above each column indicate the nucleotide position within the alignment. Nucleotide substitutions marking putative recombination
regions are marked in bold and underlined. A, CC113 isolates include 1 of serotype 18B (18B/2) and 6 of serotype 18C. B, CC191 isolates include 1 of
serotype 7A (7A/2) and 7 of serotype 7F. CC218 isolates all represent serotype 7F (B*). The arrow indicates the position of a single-base-pair insertion
in the 7A/2 sequence, compared with the other serogroup 7 sequences.
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DISCUSSION
Within our collection of historical and modern pneumococci,
we identiﬁed 36 independent capsular switching events. Ap-
proximately 94% of the variants were isolated prior to the in-
troduction of PCV7 and were roughly evenly distributed
through time (Figure 1). The collection was not designed for
inferring a capsular switching rate; nevertheless, these data
imply that this phenomenon has been a regular occurrence
(ie, there is evidence of capsular switching within a diverse
range of CCs) every decade throughout the past 7 decades).
Analysis of the cps loci of 10 representatives of CC66 indi-
cated multiple independent changes to the same serotype, sup-
porting the notion that capsular switching may occur
regularly among pneumococci. Within this CC, an initial cap-
sular switch from serotype 7B to 9N no later than 1952 was
followed by at least 2 independent changes to serotype 19F no
later than 1972 and 2005 and by at least 3 independent
changes to serotype 14, each no later than the mid-1990s. This
is consistent with previous studies that demonstrated multiple
changes of serotype within the same CC: CC156/1629V→14
[39–41], CC8123F→19F/A [30], and CC6954→19A [25, 28].
We studied 18 capsular switching events in detail. Three of
these were presumably the result of nucleotide substitution
and/or deletion, a ﬁnding consistent with previous work [2].
The remaining 15 events appeared to be due to recombina-
tion, and breakpoints for 11 events could be estimated by
comparison of the cps loci and ﬂanking sequences of the puta-
tive ancestors, donors, and recombinants. The capsular switch
recombination fragments identiﬁed here (ie, imports of
various lengths, inserted at different points around the cps
locus, with or without the adjacent pbp sequences) are consis-
tent with fragments detected in previously published studies
[25, 42, 43]. Figure 5 depicts the exchange of cps loci between
CCs, as inferred by our data. Isolates identiﬁed as donors
from our collection could possibly have represented different
CCs than the true donors; however, even if this were true, our
Figure 5. Inter-clonal complex (CC) cps locus transfers inferred in this study. Circles represent pneumococcal CCs as named. Arrows indicate transfer
of cps loci between CCs, as inferred from nucleotide sequence analyses for 15 capsular switching events. Donor CCs could not be predicted for a total
of 7 events because donor isolates were not present among this collection. Arrow labels indicate serotypes associated with the transferred cps loci and
isolation year of the oldest recombinant pneumococcus in this collection.
Figure 4. Genetic changes leading to capsular switching within clonal
complexes (CCs) 191, 218, and 574. Bars represent the cps locus and
ﬂanking regions. Filled arrows indicate the relative positions of the dexB
(left) and aliA (right) loci. Open arrows indicate the relative positions of
the pbp2x (left) and pbp1a (right) loci. Vertical bisecting lines indicate
single nucleotide substitutions. Recombination fragments are indicated
by coloring. Regions bounded by solid lines are depicted at their
maximum length. Regions not bounded by solid lines are represented at
their minimum length (Table 2). The asterisk indicates a single-base-pair
insertion. The schematic is drawn approximately to scale.
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conclusions about the number of independent capsular
switches and the range of recombination fragment sizes would
remain unchanged.
Our analyses did not indicate any recombination breakpoint
hot spots around the cps locus, which had also not been indi-
cated by any previous studies [25, 27, 28, 30]. It is impossible
to know whether the putative imports were acquired through
single or multiple recombination events, but the former is
most parsimonious. The import lengths were estimated to
range from approximately 19.0 to ≥58.2 kb (and apart from 1
example, always included the entire cps locus) and did not
show any trends toward increasing/decreasing lengths through
time.
The CC21812F→7F and CC667B→9N events were character-
ized by large (>50 kb) recombination imports and must have
taken place no later than 1952 and 1960, respectively. Large-
scale recombination between pneumococci has therefore
clearly been occurring for decades, although the technology
capable of detecting and detailing such events has only recent-
ly become available [25, 28, 30, 42]. Additionally, both of these
putative imports included the pbp2x + cps + pbp1a loci, as re-
ported for other events [27, 28] and for another newly charac-
terized event in this study (CC156/1629V→19A).
Recently reported in vivo pbp2x ± cps ± pbp1a recombina-
tion events were detected soon after widespread vaccination
began in the United States. No such recombinants had been
reported before in nature, and the imported pbp2x and pbp1a
sequences conferred penicillin nonsusceptibility. Thus, it was
theorized that vaccine-induced and/or antibiotic-induced se-
lective pressures may play a role in driving these genetic
changes [28, 44]. Penicillin was introduced in the 1940s; oral
penicillins were not available until the mid-1950s, and their
use was initially limited. Consequently, our analyses question
the above theory because the CC21812F→7F and CC667B→9N
events were both associated with penicillin-susceptible pneu-
mococci and occurred before the widespread use of penicillins
and before the introduction of PCV7. Our new data suggest
that recombination of the cps locus and ﬂanking regions
might be “normal” biological processes, the evolution of
which has undoubtedly been inﬂuenced by naturally occurring
immunity and other selective pressures. Presumably, vaccine-
induced immune pressures and/or the pressure of antibiotic
use subsequently inﬂuence the spread and maintenance of ad-
vantageous genes (and/or alleles) by selecting recombinants
that are best able to survive. However, the potential negative
effects should not be underestimated: the CC6954→19A
“vaccine escape” capsular switches in the United States were
ﬁrst recovered from patients with pediatric invasive pneumo-
coccal disease only 3 years after PCV7 introduction and, 2
years later, were the third-most common serotype 19A CC
causing invasive pneumococcal disease among all age groups
[20]. These strains were penicillin nonsusceptible, owing to
the simultaneous acquisition of altered pbp2x and pbp1a
genes. Consequently, the increase in prevalence of these
strains likely contributed to the increase in pneumococcal
penicillin nonsusceptibility in the United States after PCV7 in-
troduction [20, 45].
Another interesting ﬁnding was that a CC19919A-like repre-
sentative was the most probable donor of the 19A cps locus
and ﬂanking pbps to the CC156/16219A isolates described in
this study. CC19919A representatives were also the donors of
the cps locus ± pbps to the vaccine escape progeny [25, 28] and
an ST32019→19A cps locus switch [27]. Future studies will
attempt to uncover an explanation of why CC19919A represen-
tatives appear to be “good” cps locus donors.
Our analyses also revealed recombination at the cps locus
that did not result in capsular switching, among isolates be-
longing to the same ancestral lineages (CC11318C and
CC1917F) and different ancestral lineages (CC1917F vs
CC2187F and CC1514 vs CC12414). Similar events have been
noted within the CC8123F lineage [26] and among serogroup 6
and 19 isolates [10–12]. We speculate that this is more likely
to be the result of recombination whereby some genes are
coincidentally exchanged, rather than the result of exchange
that occurred directly in response to selection pressure. It
could also be the result of DNA repair mediated by recombi-
nation at or near the cps locus. A comparison of the cps loci of
CC1514 and CC12414 representatives also indicated a deletion
in the CC1514 wciY gene, resulting in a predicted truncation
of the putative glycerol phosphotransferase encoded by this
gene. Notwithstanding the deletion, the CC1514 isolates were
successfully serotyped by the Quellung reaction, indicating
successful capsule production. Indeed, an in silico analysis of
the predicted cps protein coding regions failed to identify a
speciﬁc reaction catalyzed by the serotype 14 version of this
protein [46].
Given the overall capacity for cps locus recombination, the
associations between genotypes and serotypes are puzzling, as
is our evidence of a high level of cps sequence conservation
within some CCs (eg, CC1917F and CC21812F). Perhaps there
is some synergism between serotype and the genetic back-
ground of a strain that conveys an advantage to certain combi-
nations over others. This sort of synergistic effect has been
invoked to explain changes in the pneumococcal population
in South Korea, where there was a prevaccine reduction of
multidrug-resistant CC271/32019F pneumococci and replace-
ment by similarly multidrug-resistant CC271/32019A pneumo-
cocci over several years [47]. It is also possible that genes, such
as those encoding sugar-biosynthesis enzymes, outside the cps
locus contribute to capsular expression and facilitate a geno-
type/serotype association [2].
Our collection of pneumococci provided a unique opportu-
nity to study evolution at the cps locus over approximately 70
years. Capsular switching with/without simultaneous pbp
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transfer has occurred regularly and prior to both PCV7 intro-
duction and widespread antibiotic use. It is highly likely that
the proliferation of newly generated NVT capsular switch var-
iants will continue to be favored by PHiD-CV and PCV13
vaccination programs, as was the case after PCV7 implemen-
tation. Penicillin-nonsusceptible variants will have an even
greater advantage. Although the magnitude of these selective
forces relative to those favoring established genotype/VT
associations remains unclear, the implementation of vaccine
programs across the globe will most likely favor the inter-
continental spread of NVT and penicillin-nonsusceptible
pneumococci.
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